Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs) EQUITY
$155.01
neg -0.42
-0.27%
Today's Range: 154.79 - 156.13 | AMGN Avg Daily Volume: 3,655,800
Last Update: 05/26/17 - 4:00 PM EDT
Volume: 2,731,557
YTD Performance: 6.31%
Open: $155.60
Previous Close: $155.43
52 Week Range: $130.09 - $181.81
Oustanding Shares: 735,399,128
Market Cap: 114,303,086,465
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 5 6 6
Moderate Buy 1 1 1 1
Hold 10 10 9 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.37 2.28 2.16 2.16
Latest Dividend: 1.15
Latest Dividend Yield: 2.96%
Dividend Ex-Date: 05/15/17
Price Earnings Ratio: 14.76
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
14.76 14.70 29.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-10.96% -0.35% 35.95%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.10 0.20 0.07
Net Income 11.30 0.50 0.15
EPS 13.00 0.50 0.15
Earnings for AMGN:
EBITDA 12.03B
Revenue 22.99B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $3.09 $3.10 $12.39 $12.58
Number of Analysts 10 8 13 13
High Estimate $3.19 $3.21 $12.81 $13.13
Low Estimate $3.01 $2.92 $12.07 $11.90
Prior Year $2.84 $3.02 $11.65 $12.39
Growth Rate (Year over Year) 8.84% 2.57% 6.34% 1.57%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Intermediate Trade: QQQ Real Money Pro($)

The tactic is the bearishly biased, calendar diagonal call spread, which controls the risk of the trade.

Takeaways and Observations Real Money Pro($)

"Success breeds complacency. Complacency breeds failure. Only the paranoid survive." - Andy Grove   Perhaps this qu…
It is hard to keep up with the flurry of first-quarter earnings reports hitting the wires this morning. Here are a few that caught my eye today.
You think the exchange is overvalued? I don't, and here's why.
Get your plan in place, but understand that the Republic is not in jeopardy.
Update
Mar 21, 2017 | 7:15 AM EDT
Thomson ONE Oppenheimer Healthcare Conference (Day 1 of 2) - 03/21/17 - 03/22/17 New York, NY
These stocks are showing signs of changing direction.
Today's session is reminiscent of a pre-Trump day.

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.